SHTDY

$10.63+$0.03 (+0.33%)live

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$10.00 – $14.87

13% from low

Exchange

OTC Link

ADRC

Change$-0.18

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$591.0B	+0.9%	$0.00	$0.00–$0.00	—	0
2027	$619.3B	+4.8%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Beat consensus in 4 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-04-23	$1.27	$1.31	+3.1%
2025-08-21	$1.06	$1.21	+14.2%
2025-03-20	$1.50	$1.14	-24.0%
2024-10-25	$1.48	$1.28	-13.5%
2024-04-26	$1.66	$1.76	+6.0%
2023-10-27	$1.45	$1.42	-2.1%
2023-04-27	$1.75	$1.76	+0.6%
2022-06-30	$1.45	$1.39	-4.1%

Intrinsic value

$83.13

Price

$10.63

Implied upside

+682%

Symbol	Price	Today	Mkt cap	P/E
SHTDYSinopharm Group Co. Ltd.	$10.63	+0.33%	$6.6B	—
GIFOFGrifols, S.A.	$8.85	+0.00%	$8.7B	—
MSMKFMatsukiyoCocokara & Co.	$14.88	+0.00%	$5.9B	—
SHPMFShanghai Pharmaceuticals Holding Co., Ltd	$1.46	+0.00%	$8.5B	—
SHPMYShanghai Pharmaceuticals Holding Co., Ltd	$7.47

No one on the platform currently holds SHTDY.

Institutions holding (13F)

No tracked institution reports a position in SHTDY as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

TTM yield · 14.97% ($1.59/share)

No one on the platform has traded SHTDY yet.